News Group News

A new lead in FAIR data

22. December 2021

HITS researcher Ulrike Wittig will be a new lead in the data platfom of the European life science organization ELIXIR. She …

Read more

Computing drug-target binding kinetics: three papers in the Journal of Chemical Theory and Computation

20. December 2021

How long does a drug molecule stay bound to its protein target? How quickly does it bind to and dissociate from …

Read more

New Research Project: Mathematical Oncology in Heidelberg

9. December 2021

An interdisciplinary team of researchers from Heidelberg is working together to develop mathematical modeling to help decipher tumor development in hereditary …

Read more

Revisiting star formation in the era of big data

1. December 2021

HITS group leader Kai Polsterer selected member of an international team at the International Space Science Institute Kai Polsterer, head of …

Read more

How can a surface guide centriole assembly?

30. November 2021

Centrioles are cell organelles with a cylindrical shape and a 9-fold radially symmetric architecture. They play a role in the formation …

Read more

“TULIPS” lets astronomy flourish in the classroom

30. November 2021

HITS researcher Eva Laplace has developed a software that visualizes the evolution of stars in short movies. For this project that …

Read more
Job

Congratulations Florian Franz

18. November 2021

We would like to congratulate Florian Franz who successfully defended his PhD thesis last week! Congratulations! The whole MBM group wishes …

Read more

Printing fuel cell membranes: Simulations of shear thinning in Nafion

17. November 2021

Fuel cells offer a promising energy generation alternative for a wide range of technologies thanks to their ecological friendliness and unparalleled …

Read more

Paper accepted at NeurIPS 2021!

19. October 2021

Federico López, NLP group PhD candidate, is the first author of a paper that was accepted as a spotlight paper …

Read more

Searching for a way out of the brain fog caused by COVID-19

1. October 2021

HITS is a partner in the new EU-funded research program “BRAVE” that proposes tackling COVID-19 brain inflammation with computer-designed molecules. The …

Read more

Switch to the German homepage or stay on this page